- Home
- DAN vs DYN Comparison
DAN vs DYN Comparison
Compare DAN & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAN | DYN |
|---|---|---|
| Founded | 1904 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.0B |
| IPO Year | 1998 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DAN | DYN |
|---|---|---|
| Price | $31.21 | $17.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 14 |
| Target Price | $35.00 | ★ $37.00 |
| AVG Volume (30 Days) | 1.3M | ★ 2.2M |
| Earning Date | 04-29-2026 | 03-02-2026 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | ★ 264.10 | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $7,500,000,000.00 | N/A |
| Revenue This Year | $1.92 | N/A |
| Revenue Next Year | $3.60 | N/A |
| P/E Ratio | $49.86 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.11 | $7.01 |
| 52 Week High | $36.28 | $25.00 |
Technical Indicators
Market Signals| Indicator | DAN | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 42.02 | 50.66 |
| Support Level | $28.30 | $16.34 |
| Resistance Level | $31.73 | $20.08 |
| Average True Range (ATR) | 1.20 | 1.18 |
| MACD | -0.37 | 0.14 |
| Stochastic Oscillator | 7.99 | 52.31 |
Price Performance
Historical ComparisonAbout DAN Dana Incorporated
Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.